Comments
Suven Life Sciences’ Pashamylaram facility near Hyderabad has undergone successful inspection by the US health regulator.
The facility has undergone renewal inspection from February 5-18 by the United States Food and Drug Administration (USFDA), Suven Life Sciences said in a filing to BSE today.
The plant is considered to be in an acceptable state of compliance with regard to current good manufacturing practices (CGMP) and the agency has issued an establishment inspection report (EIR) for the facility, it added.
So far the company has filed 19 drug master files and 5 abbreviated new drug applications. The company’s stock was trading 5.43 per cent up at Rs 191.10 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.